Sulindac.
D000893:Anti-Inflammatory Agents; D001597:Benzylidene Compounds / Q000627:therapeutic use*; D004341:Drug Evaluation; D007192:Indenes / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D001597:Benzylidene Compounds; D007192:Indenes